Enabling CAR T‐cell therapies for HIV‐positive lymphoma patients – A call for action
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enabling CAR T‐cell therapies for HIV‐positive lymphoma patients – A call for action
Authors
Keywords
-
Journal
HIV MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-06-16
DOI
10.1111/hiv.13514
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
- (2022) J. Joseph Melenhorst et al. NATURE
- Axicabtagene Ciloleucel in Patients Ineligible for ZUMA-1 Because of CNS Involvement and/or HIV: A Multicenter Experience
- (2022) Carlen A. Yuen et al. JOURNAL OF IMMUNOTHERAPY
- Successful administration of chimeric antigen receptor (CAR) T-cell therapy in patients requiring hemodialysis
- (2022) Bradley D. Hunter et al. Experimental Hematology & Oncology
- Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial
- (2022) Manali Kamdar et al. LANCET
- Observational Cohort Study of People Living with HIV (PWH) Treated with CD19-Directed CAR T Cell Therapy for B-Cell Lymphoid Malignancies - Interim Results of AIDS Malignancy Consortium (AMC) Study AMC-113
- (2022) Stefan K. Barta et al. BLOOD
- Trial-in-Progress: AMC 112: Axicabtagene Ciloleucel in Relapsed or Refractory HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphoma (NCT05077527)
- (2022) Zachary D. Epstein-Peterson et al. BLOOD
- Biomarkers for Predicting Cytokine Release Syndrome following CD19-Targeted CAR T Cell Therapy
- (2021) Victor E. Tedesco et al. JOURNAL OF IMMUNOLOGY
- Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
- (2021) Nikhil C. Munshi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characteristics and outcome of human immunodeficiency virus (HIV)‐associated primary effusion lymphoma as observed in the German HIV‐related lymphoma cohort study
- (2021) Marcus Hentrich et al. BRITISH JOURNAL OF HAEMATOLOGY
- CAR-T cell therapy: current limitations and potential strategies
- (2021) Robert C. Sterner et al. Blood Cancer Journal
- False-Positive Human Immunodeficiency Virus Test Results in Patients Receiving Lentivirus-Based Chimeric Antigen Receptor T-Cell Therapy: Case Report, Review of the Literature, and Proposed Recommendations
- (2021) Julian A Villalba et al. JOURNAL OF INFECTIOUS DISEASES
- Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
- (2021) Nathan Hale Fowler et al. NATURE MEDICINE
- Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
- (2021) Frederick L. Locke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Optimal fludarabine lymphodepletion is associated with improved outcomes following CAR T-cell Therapy
- (2021) Vanessa A Fabrizio et al. Blood Advances
- Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis
- (2020) Ahmed Abbasi et al. Journal of Hematology & Oncology
- KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
- (2020) Michael Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric antigen receptor T-cell therapy for HIV-associated diffuse large B-cell lymphoma: case report and management recommendations
- (2020) Jeremy Allred et al. BONE MARROW TRANSPLANTATION
- Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity
- (2020) Caron A. Jacobson et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidemiology of haematological malignancies in people living with HIV
- (2020) Stephen M Kimani et al. Lancet HIV
- Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016
- (2020) Julia L. Marcus et al. JAMA Network Open
- Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies
- (2020) Elizabeth L. Siegler et al. Frontiers in Immunology
- Engineering better chimeric antigen receptor T cells
- (2020) Hao Zhang et al. Experimental Hematology & Oncology
- Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study
- (2019) Raúl U Hernández-Ramírez et al. Lancet HIV
- Risks and outcomes of allogeneic hematopoietic stem cell transplantation for hematologic malignancies in patients with Human immunodeficiency virus Infection
- (2019) Shukaib Arslan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment
- (2019) Yuqing Gong et al. Expert Opinion on Drug Metabolism & Toxicology
- Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: the BMT CTN-0903/AMC-080 Trial
- (2019) Richard F. Ambinder et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Successful anti‐CD19 CAR T‐cell therapy in HIV‐infected patients with refractory high‐grade B‐cell lymphoma
- (2019) Jeremy S. Abramson et al. CANCER
- Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy
- (2019) Sophia Stock et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Malignant lymphoma in the HIV-positive patient
- (2018) Anne Meister et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study
- (2018) Philipp Schommers et al. HAEMATOLOGICA
- Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study
- (2018) Philipp Schommers et al. HAEMATOLOGICA
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research HIV Working Group
- (2017) Thomas S. Uldrick et al. JOURNAL OF CLINICAL ONCOLOGY
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment
- (2017) Olof Elvstam et al. PLoS One
- CAR-T cell manufacturing: time to put it in gear
- (2017) Alexey Bersenev TRANSFUSION
- HIV-Associated Malignant Lymphoma
- (2017) Uta Brunnberg et al. Oncology Research and Treatment
- Impact of low-level viraemia on virological failure in HIV-1-infected patients with stable antiretroviral treatment
- (2016) Jordi Navarro et al. ANTIVIRAL THERAPY
- Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial
- (2016) J. C. Alvarnas et al. BLOOD
- Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients
- (2016) V Bouteloup et al. HIV MEDICINE
- CAR T Cell Therapy: A Game Changer in Cancer Treatment
- (2016) Hilde Almåsbak et al. Journal of Immunology Research
- Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma
- (2015) S. K. Barta et al. ANNALS OF ONCOLOGY
- Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States
- (2015) Anna E. Coghill et al. JOURNAL OF CLINICAL ONCOLOGY
- Factors Associated With Plasma IL-6 Levels During HIV Infection
- (2015) Álvaro H. Borges et al. JOURNAL OF INFECTIOUS DISEASES
- Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma
- (2015) H Saito et al. Blood Cancer Journal
- Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort
- (2014) Philipp Schommers et al. BRITISH JOURNAL OF HAEMATOLOGY
- Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome
- (2012) C. Charpentier et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era
- (2012) Silvia Montoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation
- (2009) J. L. Diez-Martin et al. BLOOD
- Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic)
- (2009) Charlotte Lewden et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started